Key facts
- SNIP Medical’s last known valuation is $1.7M (Apr 2025).
- It has raised $580K; the latest was Later Stage VC ($390K) in Apr 2025.
- Notable investors include Innovate UK, SFC Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for SNIP Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for SNIP Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SNIP Medical
Developer of a patented intra-oral frenotomy device designed to standardize and accelerate tongue-tie diagnosis and treatment in newborns. The company's device offers a protected guided incision mechanism, integrated passive and active safety features, reproducible treatment design, and simplified clinical training, enabling healthcare professionals treating tongue-tied newborns and infants to deliver faster, safer procedures that support early and effective breastfeeding.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2020
- Employees
- 2
- Website
- snipmedical.com/
- Ownership
- Privately Held (backing)
SNIP Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SNIP Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SNIP Medical in its N-PORT filings yet. We sweep new filings monthly.